Publication details

Cholinergic Anti-inflammatory Pathway and Stroke

Investor logo


Year of publication 2017
Type Article in Periodical
Magazine / Source Current Drug Delivery
MU Faculty or unit

Faculty of Medicine

Field Pharmacology and pharmaceutical chemistry
Keywords Cerebral ischemia; cholinergic anti-inflammatory pathway; inflammation; intracerebral hemorrhage; stroke; subarachnoid hemorrhage; Vagus nerve stimulation; alpha 7 nicotinic acetylcholine receptor (alpha 7 nAChR)
Description Background: Stroke is devastating cerebrovascular event which is responsible for 6.7 million deaths each year worldwide. Inflammation plays an important role in the pathophysiology of stroke. Targeting inflammation after stroke is highly actual topic for both experimental and clinical research. Methods: Research articles related to cholinergic anti-inflammatory pathway (CHAIP) and stroke were reviewed. The first part of review describes the basic characteristics of inflammatory response after stroke, main components and function of CHAIP. The second part reviews studies focused on CHAIP as a therapeutic target for ischemic and hemorrhagic stroke. Both pharmacological stimulation of alpha 7 nAChR and vagus nerve stimulation after stroke are reviewed. Results: Cholinergic anti-inflammatory pathway (CHAIP) is a physiological mechanism by which central nervous system regulates immune response and controls inflammation. Vagus nerve, spleen and alpha 7 nicotinic acetylcholine receptor (alpha 7 nAChR) are the main components of CHAIP. Conclusion: Targeting cholinergic anti-inflammatory pathway is a promising way of immunomodulation which attenuates inflammation in a complex manner without causing immunosuppression.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info